Bloomberg Intelligence cover image

Intel to Sell 51% Altera Stake to Silverlake

Bloomberg Intelligence

00:00

Pfizer's Strategic Moves in Obesity Treatments

This chapter examines Pfizer's strategic approach to obesity treatments and their development of a new oral GLP-1 medication for diabetes. It also discusses market release timelines and the impact of competitive data from Chinese biotechs on Pfizer's position.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app